FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma.
Bigley AB, Spade S, Agha NH, Biswas S, Tang S, Malik MH, Dai L, Masoumi S, Patiño-Escobar B, Hale M, DiPierro G, Martell R, Hann B, Shah N, Wiita AP, Liu X.
Bigley AB, et al. Among authors: dai l.
Blood Adv. 2021 Aug 10;5(15):3021-3031. doi: 10.1182/bloodadvances.2020002440.
Blood Adv. 2021.
PMID: 34357379
Free PMC article.